Literature DB >> 16208038

Stable and consistent genetic profile of Oka varicella vaccine virus is not linked with appearance of infrequent breakthrough cases postvaccination.

Ventzislav Vassilev.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16208038      PMCID： PMC1248474          DOI： 10.1128/JCM.43.10.5415-5417.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  11 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.

Authors:  Mark L Quinlivan; Anne A Gershon; Sharon P Steinberg; Judith Breuer
Journal:  J Infect Dis       Date:  2004-07-15       Impact factor: 5.226

3.  Live vaccine used to prevent the spread of varicella in children in hospital.

Authors:  M Takahashi; T Otsuka; Y Okuno; Y Asano; T Yazaki
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

4.  Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-05-28

5.  Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity.

Authors:  Y Gomi; T Imagawa; M Takahashi; K Yamanishi
Journal:  J Med Virol       Date:  2000-08       Impact factor: 2.327

6.  The postmarketing safety profile of varicella vaccine.

Authors:  R G Sharrar; P LaRussa; S A Galea; S P Steinberg; A R Sweet; R M Keatley; M E Wells; W P Stephenson; A A Gershon
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

7.  Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.

Authors:  Andreas Sauerbrei; Elena Rubtcova; Peter Wutzler; D Scott Schmid; Vladimir N Loparev
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

8.  Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses.

Authors:  Y Gomi; T Imagawa; M Takahashi; K Yamanishi
Journal:  Arch Virol Suppl       Date:  2001

9.  Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.

Authors:  A Sauerbrei; U Eichhorn; S Gawellek; R Egerer; M Schacke; P Wutzler
Journal:  J Med Virol       Date:  2003-10       Impact factor: 2.327

10.  Molecular diagnosis of zoster post varicella vaccination.

Authors:  Andreas Sauerbrei; B Uebe; P Wutzler
Journal:  J Clin Virol       Date:  2003-07       Impact factor: 3.168
View more
  2 in total

1.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.